rel-1,3-Dioxoisoindolin-2-yl (1R,2R)-2-(trifluoromethyl)cyclopropane-1-carboxylate

Catalog No. :
ACDMVX533
CAS No. :
2248413-94-5
Molecular Formula :
C13H8F3NO4
Molecular Weight :
299.20

IUPAC Name:1,3-dioxoisoindolin-2-yl (1R,2R)-2-(trifluoromethyl)cyclopropane-1-carboxylate

rel-1,3-Dioxoisoindolin-2-yl (1R,2R)-2-(trifluoromethyl)cyclopropane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$412.00Login to see priceInquiryInquiry
100mg98%$604.00Login to see priceInquiryInquiry
250mg98%$858.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-1,3-Dioxoisoindolin-2-yl (1R,2R)-2-(trifluoromethyl)cyclopropane-1-carboxylate
IUPAC Name1,3-dioxoisoindolin-2-yl (1R,2R)-2-(trifluoromethyl)cyclopropane-1-carboxylate
Molecular FormulaC13H8F3NO4
Molecular Weight299.20
SMILESO=C([C@H]1[C@H](C(F)(F)F)C1)ON(C(C2=C3C=CC=C2)=O)C3=O
InChI KeyJRHJPAJFYOAUOS-RKDXNWHRSA-N
Synonymrac-1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl (1R,2R)-2-(trifluoromethyl)cyclopropane-1-carbox ylate;Cyclopropanecarboxylic acid, 2-(trifluoromethyl)-, 1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl ester, (1R,2R)-rel-
CAS No.2248413-94-5

Synthetic Route by SureRoute

1. ACDMVX533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNXUH296 route compound structure diagram
    ACNXUH2961774-47-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDMVX533 route product structure diagram
    ACDMVX5332248413-94-5
Inquiry

2. ACDMVX533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEZAK614 route compound structure diagram
    ACEZAK6141932455-67-8 In Stock
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9 In Stock
  4. Then
  5. ACDMVX533 route product structure diagram
    ACDMVX5332248413-94-5
Inquiry

Comments (0)